Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept for Pityriasis Rubra Pilaris
NCT00815633Phase 4Terminated
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of alefacept in pityriasis rubra pilaris (PRP). Started Dec 2008; status: terminated.
02
Drugs
alefacept
03
Conditions
pityriasis rubra pilaris (PRP)
Beyond the preview
Go deeper on NCT00815633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815633.